This provides a valuable indicator of the extent of kidney damage and, over time, the rate at which kidney function is being lost, and flags the possibility of kidney diseases other than diabetic nephropathy
Administration of semaglutide at the dose regimen of ~ 90 g/kg/day failed to evidence significant weight loss but more importantly, led to alteration of cortical bone microarchitecture, represented by lower cortical thickness, and ultimately to a significant decrease in bone strength [69]
That said, if you need the medication for medical reasons such as diabetes, the benefits may outweigh the risks and that decision should always be made with your healthcare provider
The fix isn't patience it's gradually moving into a productive weekly range
A GLP-1 is what made all the difference for me
Across the broader telehealth GLP-1 market, monthly totals commonly range from roughly $200 to $700 or more, which is the band to expect once standard dosing is factored in
